Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Curon Stretta

This article was originally published in The Gray Sheet

Executive Summary

Voluntary recall of all affected lots of the catheters for treatment of gastroesophageal reflux disease (GERD) is complete, Curon announces Jan. 5. A "manufacturing irregularity" related to 278 catheters "has been identified, and we have resumed normal manufacturing processes," Curon says. The firm does not expect "a major impact" on 2001 fiscal year results, according to President and CEO John Morgan. The device received 510(k) clearance in April (1"The Gray Sheet" Oct. 2, 2000, p. 16)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT014319

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel